The Pharmacy Times® Chronic Obstructive Pulmonary Disease (COPD) Disease Resource Center is a comprehensive resource for clinical news and expert insights on a group of diseases that cause airflow blockage and breathing-related problems, including emphysema and chronic bronchitis.
July 30th 2025
Astegolimab shows promise in reducing chronic obstructive pulmonary disease (COPD) exacerbations, offering hope for improved management of this debilitating lung disease.